Genentech’s TNKase gets new approval; Sanofi gives up rights to oncology candidate

Plus, news about Nuvation Bio, Leqembi, IN8bio and Syros:

Longtime clot-busting drug gets new approval: Roche and Genentech’s TNKase (tenecteplase) was

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Catheter ablation linked to lower risk of dementia in all patients with atrial fibrillation

Previous studies have shown a link between catheter ablation and a lower risk of dementia and premature death for patients with atrial fibrillation.

August 23, 2023

WHO recommends dropping component of many flu vaccines

The World Health Organization has recommended dropping a component of many flu vaccines because the viruses it protects against appear to have been driven into

September 29, 2023

Why is health care cybersecurity so bad?

Year after year, more Americans are affected by health care data breaches. Though health savings accounts, pharmacies, and major hospitals have all been attacked in

December 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.